⚡️⚡️⚡️⚡️⚡️⚡️
We identified a significant wave of insider purchases🌊
In recent days, significant and unusual insider activity was recorded in Lilly ($LLY) stock, with three directors,
the CEO and his deputy made extensive purchases ranging from $75,000 to $1 million each. 🕯
Here are the purchases we identified - 🔎
✔️ Executive - $120k ✔️ Executive - $1M ✔️ Executive - $75K ✔️ Company Vice President - $630K ✔️ Company CEO - $1M
Eli Lilly is a leading international pharmaceutical company, focusing on developing innovative drugs in areas such as mental health. The company is known for developing breakthrough drugs and invests heavily in research and development. 💊
We are monitoring. 🔎